Abbvie Inc (ABBV)
194.00 x 3 196.92 x 7
Post-market by (Cboe BZX)
195.10 +1.59 (+0.82%) 04/30/25 [NYSE]
194.00 x 3 196.92 x 7
Post-market 194.13 -0.97 (-0.50%) 18:07 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ABBV | JNJ | NVO | ||
| Company | Abbvie Inc | Johnson & Johnson | Novo Nordisk A/S ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 194.49 | 158.20 | 66.47 | ||
| High | 195.78 | 158.20 | 66.64 | ||
| Low | 191.01 | 155.02 | 65.40 | ||
| Last | 195.10 | 156.31 | 66.45 | ||
| Change | +1.59 | +0.40 | +1.29 | ||
| % Change | +0.82% | +0.26% | +1.98% | ||
| Volume | 8,393,421 | 9,586,219 | 9,236,916 | ||
| 20-Day Average Volume | 9,828,751 | 10,674,081 | 10,662,485 | ||
| Previous Close | 193.51 | 155.91 | 65.16 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 182.70 | 154.35 | 63.21 | ||
| 20-Day Raw Stochastic | 66.33% | 77.36% | 80.63% | ||
| 20-Day Relative Strength | 54.14% | 49.26% | 46.07% | ||
| Weighted Alpha | +16.56 | +3.56 | -51.45 | ||
| Today's Opinion | 16% Buy | 8% Buy | 88% Sell | ||
| Previous Opinion | 8% Buy | 8% Buy | 88% Sell | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.19% since 04/23/25 | +0.60% since 04/23/25 | +8.40% since 04/23/25 | ||
| Low | 176.11 on 04/24/25 | 152.45 on 04/25/25 | 60.57 on 04/25/25 | ||
| High | 195.78 on 04/30/25 | 158.20 on 04/30/25 | 66.64 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | -4.96% since 03/28/25 | -4.52% since 03/28/25 | -4.11% since 03/28/25 | ||
| Low | 164.39 on 04/09/25 | 141.50 on 04/09/25 | 57.00 on 04/21/25 | ||
| High | 212.15 on 04/01/25 | 166.63 on 03/31/25 | 70.00 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | +11.07% since 01/30/25 | +2.25% since 01/30/25 | -22.13% since 01/30/25 | ||
| Low | 164.39 on 04/09/25 | 141.50 on 04/09/25 | 57.00 on 04/21/25 | ||
| High | 218.66 on 03/10/25 | 169.99 on 03/04/25 | 93.80 on 02/25/25 | ||
| 6-Month | |||||
| %Chg | -3.18% since 10/30/24 | -2.68% since 10/30/24 | -41.32% since 10/30/24 | ||
| Low | 163.81 on 11/19/24 | 140.68 on 01/10/25 | 57.00 on 04/21/25 | ||
| High | 218.66 on 03/10/25 | 169.99 on 03/04/25 | 113.02 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 342,314,912 | 375,130,848 | 292,407,616 | ||
| Shares Outstanding, K | 1,768,978 | 2,406,073 | 4,487,532 | ||
| Annual Sales | 56,334,000,000 | 88,821,000,000 | 42,108,430,000 | ||
| Annual Net Income | 4,278,000,000 | 14,066,000,000 | 14,643,260,000 | ||
| Last Quarter Sales | 13,343,000,000 | 21,893,000,000 | 12,261,320,000 | ||
| Last Quarter Net Income | 1,286,000,000 | 10,999,000,000 | 4,026,620,000 | ||
| 60-Month Beta | 0.55 | 0.49 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 04/25/25 | 2.77 on 04/15/25 | 0.91 on 02/05/25 | ||
| Latest Earnings Date | 04/25/25 | 04/15/25 | 05/07/25 | ||
| Most Recent Dividend | 1.640 on 04/15/25 | 1.240 on 02/18/25 | 0.819 on 03/31/25 | ||
| Next Ex-Dividends Date | 04/15/25 | 05/27/25 | 03/31/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 18.73 | 15.46 | 19.03 | ||